| Abstract: |
Diagnosis of life-threatening illness now meets Diagnostic and Statistical Manual of Mental Disorders(4th ed.; DSM-IV; American Psychiatric Association, 1994)criteria for traumatic stressor exposure for posttraumatic stress disorder (PTSD). Quality of life (QOL) and PTSD-like symptoms were assessed in 55 women posttreatment for breast cancer. PTSD symptom measures included the PTSD Checklist-Civilian Version (PCL-C) and the Impact of Events Scale. QOL was assessed using the 20-item Medical Outcomes Study Questionnaire. PTSD symptomatology was negatively related to QOL, income, and age. Time since treatment, type of cytotoxic treatment, and stage of disease were unrelated to PTSD symptoms. With suggested criteria for the PCL-C, 5% to 10% of the sample would likely meet DSM-IVPTSD criteria. Findings suggest that in survivors of breast cancer, these symptoms might be fairly common, may exceed the base rate of these symptoms in the general population, are associated with reports of poorer QOL, and, therefore, warrant further research and clinical attention. © 1995 American Psychological Association. |
| Keywords: |
adult; treatment outcome; aged; aged, 80 and over; major clinical study; cytotoxic agent; doxorubicin; fluorouracil; cancer combination chemotherapy; cancer radiotherapy; combined modality therapy; methotrexate; cancer staging; quality of life; breast cancer; cyclophosphamide; breast neoplasms; questionnaire; adaptation, psychological; psychiatric status rating scales; tamoxifen; posttraumatic stress disorder; sick role; symptomatology; life event; income; psychometrics; oral drug administration; middle age; stress disorders, post-traumatic; human; female; article; support, u.s. gov't, p.h.s.; support, u.s. gov't, non-p.h.s.
|
